Skip to main content

Clinical Trials Search at Vanderbilt-Ingram Cancer Center



A Study of PY314 in Subjects With Advanced Solid Tumors

Miscellaneous

This is an open-label, multicenter, first in human, Phase 1a/1b study of PY314 in subjects
with locally advanced (unresectable) and/or metastatic solid tumors that are refractory or
relapsed to standard of care (including pembrolizumab, if approved for that indication).
Miscellaneous
I
Rini, Brian
NCT04691375
VICCUROP21102

To learn more about any of our clinical
trials, call 1-800-811-8480 or complete
the online Self-Referral Form here: